BUUU Group closes acquisition of 60% stake in Brightray Science
BUUU•Promissory note and remaining stake option
The seller also received a non-negotiable, non-transferable promissory note with an initial face amount of US$200 million, settleable only in Class A shares.
Promissory note installments are tied to Brightray net profit for fiscal years ending June 30, 2027, 2028 and 2029, at US$20 per share.
BUUU also holds a three-year call option to buy the remaining 40% of Brightray.
Acquisition closed and Brightray becomes subsidiary
BUUU Group closed its acquisition of a 60% stake in Brightray Science on Sept. 15, 2026, making Brightray a consolidated subsidiary.
Consideration included 2,000,000 Class A shares issued at a fixed price of US$20 per share.
